Cannabis Investments

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are Now Pain Free

January 30, 2012

DENVER–(BUSINESS WIRE)– Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe squamous cell carcinoma. These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and then healing after treatment with cannabis-based extracts.

Cannabis Science has been working closely with this patient who has multiple squamous cell carcinoma tumors on his head. The latest pictures indicate that this patient is making dramatic improvement using cannabis-extract topical therapy under scientific guidance from Cannabis Science.

In this pictorial sequence, you can see the tumors healing, and scabbing over. The holes, like a “bowling ball finger hole”, are now filled and scabbing over as healing appears to continue. In another set of images, tumor mass continues to degrade. The patient has also informed Cannabis Science that while using cannabis extracts he has had a sufficient reduction in pain as healing progresses.

Position A: The arrow in Figure 1 points to what was the “bowling ball finger hole” that went down to the skull and was obvious prior to any type treatment. Figure A2 shows that in just the few days since our last update, the scabbed over hole has filled in and is almost totally healed. This lesion is now totally pain free.

Position B: The arrow in Figure B1, B2, and B3 point to an orientation position. These three sequential photographs show the tumor receding from this point as tumor mass continues to degrade. A doctor who felt this tumor commented that it appears to be detached and ready to fall off. Friends and family are amazed at the rapid progress.

Position C: This tumor, after becoming open and bloody in photo 2, is now scabbed over and pain free in photo 3.

Cannabis Science works closely with numerous patients who are suffering from a variety of illnesses and self-treating their illnesses with cannabis extracts. With its global impact on so many people and often-poor treatment outcomes for patients, we have focused on cannabis extract-based treatment options for cancer. Cannabis Science has provided the scientific foundation for numerous patients suffering from cancer to make the informed decision to treat themselves with cannabis extracts.

You can view these graphic photos on the Cannabis Science website www.cannabisscience.com and click the button “View Images of 3rd Self-Medicated Patient & His Apparent Success”.

You can read more news on this 3rd patient as well on the Cannabis Science website www.cannabisscience.com and click on the breaking news button where you will find all the cancer related and updated patient news.

About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contact:
Cannabis Science Inc.
Dr. Robert J. Melamede, 1-888-889-0888
President & CEO
info@cannabisscience.com
www.cannabisscience.com
or
Robert Kane, 1-561-234-6929
Investor Relations Management
rkane@cannabisscience.com
info@cannabisscience.com
www.cannabisscience.com

View full post on News Releases

Cannabis Science Updates Latest Remarkable Follow Up Photographs Received from 3rd Cancer Patient

January 24, 2012

Cannabis Science, Inc. (OTCBB: CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to announce new remarkable photographic updates of the 3rd cancer patient, with treatment-resistant squamous cell carcinoma on his head.

Cannabis Science has been working with a number of self-medicated skin cancer patients, who are using cannabis-based extracts. Today Cannabis Science receives the latest photographs for the 3rd self-administering cancer patient, mentioned in the previous news release dated, January 11, 2012. The treatment process is ongoing, but the results have been visually dramatic, the cannabis extracts have drastically shrunk some tumors and others are gone.

You can view these graphic photos on the Cannabis Science website http://www.cannabisscience.com and click the button “View Images of 3rd Self-Medicated Patient & His Apparent Success”.

Cannabis Science is waiting for updated documentation and images on the 4th and 5th patient who are currently being treated with cannabis-based therapy. They are getting major results from the patients and couldn’t be more pleased with the progress.

Cannabis Science is a patient oriented company. As such, we work closely with a number of patients suffering from a variety of illnesses. Because of its global impact on so many people, and often-poor treatment outcomes for patients, we have been focusing on cannabis extract-based treatment options for cancer. Cannabis Science has provided the scientific foundation for numerous patients suffering from cancer to make the informed decision to treat themselves with cannabis extracts.

About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contacts
Cannabis Science Inc.
Dr. Robert J. Melamede, 1-888-889-0888
President & CEO
info@cannabisscience.com
www.cannabisscience.com
or
Robert Kane, 1-561-234-6929
Investor Relations Management
info@cannabisscience.com
www.cannabisscience.com

View full post on News Releases

Cannabis Science Updates Second Medical Cannabis Cancer Patient Suffering from Squamous Cell Carcinoma Photo-documents Cannabis Extracts Killing Cancerous Tumor

January 19, 2012

DENVER–(BUSINESS WIRE)–Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to announce that the second patient suffering from basal cell carcinoma (skin cancer) has self-administered cannabis extracts that appear to have eradicated the cancer.

Following up on the December 12, 2011 news release regarding a second cancer patient self-administering cannabis extract, this patient has now given the photo-documented dramatic results of treatment process. These images can be viewed on the www.cannabisscience.com website. While the treatment has been completed and the cancer seems to be gone, Cannabis Science is waiting for a full biopsy report from the physician to confirm the patient is free of cancer cells.

Currently it appears that the aforementioned patient will be able to avoid any surgical procedures such as, standard surgical excision (Mohs Surgery), and other various types of treatment for skin cancer, like chemotherapy, radiation, and cryosurgery, by using the cannabis extracts, just like the first patient mentioned in our March 9, 2011 news release.

While other treatment options may be effective for many, few patients would choose to go through a surgical procedure, and endure the side effects of radiation, or chemotherapy if a simpler and safer alternative were available. Patients self-administering cannabis extracts in the convenience of their own home appear to be effectively resolving their cancerous lesions over a period of a few weeks to a few months.

Cannabis Science is committed to making cannabis-based medicines available to the public as rapidly as possible. The Company is taking multiple approaches to accomplishing this aim in the United States. The science of cannabinoids has exploded over the past decade, laying the scientific foundation for the many medicinal uses of this unique plant. Endoannabinoids are a class of biologically active lipid compounds produced by all vertebrates (endocannabinoids) the Cannabis plant (phytocannabinoids), and more recently patentable synthetic compounds produced by chemists. Today’s modern peer-reviewed science supports the many historical uses that were discovered over thousands of years of medicinal use by herbalists.

Please visit www.cannabisscience.com to view the “Breaking News” of the successful results and images of the self-administered cancer treatments.

About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contacts

Cannabis Science Inc.
Dr. Robert J. Melamede, 1-888-889-0888
President & CEO
info@cannabisscience.com
www.cannabisscience.com
or
Robert Kane, 1-561-234-6929
Investor Relations Management
info@cannabisscience.com
www.cannabisscience.com

View full post on News Releases

VANCOUVER, B.C. and PORTLAND, Ore. (September 27, 2011) – Naturally Advanced Technologies Inc. (NAT) (OTCBB: NADVF) (TSXV: NAT) today announced that it has entered into a purchasing agreement for a minimum of one and a half million pounds of CRAiLAR Flax fiber with Brilliant Global Knitwear, the Hong Kong-based private label knitwear manufacturer which produces a broad spectrum of sweater and accessory items in natural fibers for globally recognized brands. The agreement is to com View full post on Naturally Advanced Technologies, Inc. News Feed

Buy to let property is often seen as a good investment but there are many pitfalls to watch out for along the way. Not least is the one where tenants mis-treat your property.

One such landlord had this exact problem with his buy to let property. When attending to maintenance on the property he found it to be overgrown with cannabis plant putting it on a par with the most hardened drug dens.

The lounge and two of the three bedrooms were packed to the rafters with cannabis plants that had a street value of 100,000 pounds and vast quantities of fertiliser were found in the rest of the property. Not the sort of thing you usually expect when you rent out your buy to let property.

Each room had a total of fifty new power sockets to accommodate the ultra violet lights. The electric bill that was estimated at 100 pounds per day but the ‘gardener’ had bypassed the meter, drawing his power straight from the mains.

All property from the house had been crammed into a garage to make this a pure cannabis factory, with the plants filling six police vans when they were confiscated. The house was being let to a Chinese couple who, on viewing, described it as perfect for their needs.

This type of report is one that would make any investor of buy to let property vary wary about who they take on as tenants but you can never be too sure. A middle aged single working woman is one landlords dream but wait until her other side comes through and she’s changed your living room into a dominatrix parlour, bringing about ever visiting customers and complaints from the neighbours.

There’s also every landlords nightmare that, despite laying down official boundaries on paper, you still end up with the DIY enthusiast who hasn’t a clue what he’s doing. You rent out your buy to let property to him and within weeks he’s knocking down walls, fitting wonky kitchens and installing bathroom suites that came off the back of his mates lorry. All this will cost time and money to put right.

You then have the nuclear family. Mum, dad and 2.4 kids all neatly turned out and masquerading as ideal tenants. Once in your property you will discover that six year old Johnny is a pyromaniac in training and little Monica has attention deficit disorder which leads her to leave taps on, causing flooding on numerous occasions (at least this puts out her brother’s fires) and swings from the light fittings when she’s bored, which is most days.

There’s the group of students that, against your better judgement, you allow to rent your property to. After six months of regular payments and inspections that reveal nothing more hideous than dirty underwear left on the floor, you begin to relax. That is, until summer comes and they throw the mother of all parties. Not a door left on its hinges, not a carpet without a cigarette burn and not a neighbour that hasn’t got up in arms about the 4am noise.

Of course, there are laws to protect tenants and landlords against problems and difficult tenants can be evicted. But this doesn’t get you out of the problem that horrendous debt run up against this address will not have a knock on effect to the house owner. And it doesn’t pay for the untold damage that some tenants leave you with.

You can take every precaution under the sun but at the end of the day, renting your buy to let property out is a hit and miss affair and all you can do is protect yourself as well as you possibly can.